Table 2. Assessment of clinical data between study groups.
| Clinical Data | Presence Frequency (%) | Absence Frequency (%) | Relative Risk | 95% CI | p |
|---|---|---|---|---|---|
| Comorbidities | |||||
| Arterial hypertension | 11/22 (50.00) | 09/20 (45.00) | 1.100 | 0.6094 to 1.983 | 0.7675 |
| Cardiovascular disease | 04/22 (18.18) | 05/20 (25.00) | 0.8148 | 0.3315 to 1.554 | 0.7139 |
| Diabetes Mellitus | 12/22 (54.55) | 08/20 (40.00) | 1.320 | 0.7375 to 2.416 | 0.3743 |
| HIV | 01/23 (4.35) | 00/20 | 1.909 | 0.3878 to 2.547 | >0.9999 |
| Neurological disease | 02/23 (8.70) | 02/20 (10.00) | 0.9286 | 0.2716 to 1.816 | >0.9999 |
| Obesity | 05/21 (23.81) | 05/17 (29.41) | 0.875 | 0.3935 to 1.588 | 0.7268 |
| Pulmonary disease | 01/20 (5.00) | 01/17 (5.88) | 0.9211 | 0.1712 to 1.952 | >0.9999 |
| Renal chronic | 03/22 (13.64) | 01/16 (6.25) | 1.342 | 0.5193 to 2.145 | 0.6245 |
| Hospitalization therapy | |||||
| Antibiotic | 22/23 (95.65) | 19/21 (90.48) | 1.61 | 0.6124 to 8.857 | 0.5988 |
| Corticoid | 08/23 (34.78) | 03/21 (14.29) | 1.6 | 0.8737 to 2.642 | 0.1685 |
| Anticoagulant | 21/23 (91.30) | 17/21 (80.95) | 1.658 | 0.7154 to 5.85 | 0.4029 |
Pulmonary disease: Asthma; Cardiovascular disease: Cardiac insufficiency and arrhythmia; Neurological disease: Ischemic stroke and Parkinson’s.